Taher Karampurwala has been elevated to Senior Director and Head of Middle East Business at Cipla. In this expanded leadership role, he will lead Cipla’s growth ambitions across the Middle East and will be relocating to the Kingdom of Saudi Arabia. This elevation reflects Cipla’s continued strategic focus on strengthening its position across the Middle East and broader emerging markets.
Taher has been associated with Cipla for nearly a decade and has played a pivotal role in driving the company’s international business growth. Most recently, he served as Cluster Head – Middle East, where he held P&L responsibility for the formulation business across the region. Prior to that, he served as Associate Director, APAC B2B Business, leading Cipla’s formulation business across key Asia-Pacific markets including Thailand, Philippines, Vietnam, Hong Kong, Indonesia, Bangladesh, Taiwan, and South Korea, with end-to-end P&L accountability.
Before joining Cipla, Taher worked with Sun Pharma as Senior Manager – Business Development, where he focused on driving inorganic growth across emerging markets through mergers & acquisitions, brand acquisitions, in-licensing, and out-licensing
initiatives. Earlier, at Ranbaxy, he served as Manager – Global Business Development and Manager – Global ARV Business, leading business development, global institutional partnerships, tender management, product strategy, budgeting, and commercial operations across international markets. He also began his professional journey with OOH Media as an Intern.
With over 15 years of experience across the global pharmaceutical industry, Taher brings deep expertise in P&L management, business development, strategic partnerships, market expansion, and M&A. His elevation reinforces Cipla’s commitment to accelerating growth across the Middle East while strengthening its leadership presence in one of the company’s most important international markets.